Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of ...

"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

By analyzing thousands of Aβ42 peptides, the scientists gained a better understanding of how mutations in Aβ affect protein ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Scientists have mapped how over 140,000 mutations affect the formation of amyloid beta fibrils, offering an unprecedented ...